Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Expects to Report $5M in Q4, Q1 2010 Receipts

This article has been corrected to note that Helicos expects the revenue to be recognized in the fourth quarter of 2009 and first quarter of 2010, rather than in its third quarter of 2009.

NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it expects to report cash receipts of $5 million from systems orders and associated reagent purchases during the fourth quarter of 2009 and first quarter of 2010.

"In the third quarter of 2009, we continued to accelerate the deployment of our Helicos Genetic Analysis System and to advance our technology," Helicos CEO Ronald Lowy said in a statement. "System orders more than doubled during the third quarter of 2009 compared to the first half of 2009, which resulted in an increase in the number of System installations from six to eleven during the quarter."

The firm said that it expects to file its third-quarter report with the US Securities and Exchange Commission on or before Nov. 14.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.